tranSMART Community Meeting 5-7 Nov 13 - Session 1: Amsterdam Community Meeting Follow Up

381 views
279 views

Published on

tranSMART Community Meeting 5-7 November Sanofi Chilly-Mazarin
Session 1
Amsterdam Community Meeting Follow Up
Kees van Bochove and Yike Guo

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
381
On SlideShare
0
From Embeds
0
Number of Embeds
77
Actions
Shares
0
Downloads
10
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

tranSMART Community Meeting 5-7 Nov 13 - Session 1: Amsterdam Community Meeting Follow Up

  1. 1. TRANSMART NOV 2013 CHILLY-MAZARIN, FRANCE Yi-Ke Guo, Imperial College – y.guo@imperial.ac.uk Kees van Bochove, The Hyve – kees@thehyve.nl
  2. 2. Since June 19, 2013 …  tranSMART 1.1 has been released (15th/Sept)  > 100 man/month effort  ~4oo code commits have been made into tranSMART repositories  >30 wiki pages created or updated  >30 discussions started on the mailing group  15 developer meetings have taken held  3 community webinars taken place  7 member organisations joined tranSMART Foundation  … and many more
  3. 3. Where are we in tranSMART?  Joint efforts by Pharma, Academic, for-profit      service providers and software venders Fully open source based Rigorously tested ( > 500 bugs fixed) With ETL scripts Documentation Public hosting
  4. 4. tranSMART V1.1 as the Base  tranSMART V1.1 is extended to support both Oracle and Postgres  Major efforts has been made towards a modular architecture with APIs  tranSMART V1.2 will be based on these efforts to integrate various separated developed “local versions” into one common platform
  5. 5. Lots of Things Learned  How to coordinate  How to balance development and release  How to promote a process within the community  How to keep innovation while delivering the needed production system  How to develop a community  How to make everyone “almost” happy
  6. 6. Lots of Challenges Ahead  Product management: requirements from a board user space with different priorities and expectations  Code management: the shared branch for release and the local development branches  Process management: centrally coordinated release process and distributed development process
  7. 7. The key : balance, balance…
  8. 8. Where do we want to go? - an open question for this meeting - some ideas:  Progress from ‘showing to each other what we do with tranSMART’ to really work together  Identify the overlap in the multiple projects and stakeholders: what brings us really together, as scientists, as developers?  Convert ideas into action by setting ourselves concrete goals with small dedicated groups
  9. 9. #1 People do great things with tranSMART The fact that we are all here (again) shows we are rallying around a common cause!
  10. 10. #2 TranSMART brings together parties that would otherwise not work together on a dayto-day basis Amsterdam: >10 pharma companies >10 universities/medical centers >10 IT companies Paris: Academic/Research Institutes : 18 Pharmaceutical Companies: 10 IT/Service companies : 19
  11. 11. #3 TranSMART needs to grow as a product. Opinion: To do that, we need to identify what is common (‘core’), and let the rest breathe!
  12. 12. #4 The TranSMART developer community needs to grow a joint working model around the core. This has very demonstratably happened in the last months, around the 1.1 release!
  13. 13. #5 TranSMART has great potential as a data sharing platform. But we need to make it easier to get data in first.
  14. 14. #6 The TranSMART community needs to develop a working model for Quality Assurance. At least from a development standpoint.
  15. 15. #7 TranSMART needs a plugin repository, to survive as an open source project. It’s starting – come to the hackathon!
  16. 16. #8 TranSMART has two distinct user communities: clinicians and bioinformaticians. We might need 2 user interfaces!
  17. 17. #9 TranSMART unites clinical data from EHR and eCRF systems, and bioinformatics data from many sources. But it has 2 distinct study types: longitudinal studies vs clinical trials / experiments.
  18. 18. #10 TranSMART would benefit from a Community Manager – someone whose fulltime job it is to connect people and ideas in the community.

×